Facioscapulohumeral muscular dystrophy (FSHD): investigations
Written and reviewed by Dr Ibrahim Imam, Consultant Neurologist. Last reviewed .
Facioscapulohumeral muscular dystrophy (FSHD): investigations. This is done to assess the impact of disease interventions.
Muscle magnetic resonance imaging (MRI)
- This is done to assess the impact of disease interventions
- It may also predict FSHD in asymptomatic or severe cases
Systemic assessments
Locked: subscribe to see this section.
References
- Tawil R. Facioscapulohumeral muscular dystrophy. Neurotherapeutics 2008; 5:601-606.
- Tawil R, Kissel JT, Heatwole C, et al; Practice Issues Review Panel of the American Association of Neuromuscular & Electrodiagnostic Medicine. Evidence-based guideline summary: evaluation, diagnosis, and management of facioscapulohumeral muscular dystrophy. Neurology 2015; 85:357-364.
- Wohlgemuth M, Horlings CGC, van der Kooi EL, et al. Respiratory function in facioscapulohumeral muscular dystrophy 1. Neuromuscul Disord 2017; 27:526-530.
- Moreira S, Wood L, Smith D, et al. Respiratory involvement in ambulant and non-ambulant patients with facioscapulohumeral muscular dystrophy. J Neurol 2017; 264:1271-1280.
- Tawil R, van der Maarel S, Padberg GW, van Engelen BG. 171st ENMC international workshop: Standards of care and management of facioscapulohumeral muscular dystrophy. Neuromuscul Disord 2010; 20:471-475.
- And 3 more. Subscribe to see the full list
Related checklists
- Facioscapulohumeral muscular dystrophy (FSHD): genetic classification
- Facioscapulohumeral muscular dystrophy (FSHD): clinical features
- Facioscapulohumeral muscular dystrophy (FSHD): variant phenotypes
- Facioscapulohumeral muscular dystrophy type 2 (FSHD 2)
- Facioscapulohumeral muscular dystrophy (FSHD): treatment